BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24946937)

  • 21. Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics.
    Straessler KM; Jones KB; Hu H; Jin H; van de Rijn M; Capecchi MR
    Cancer Cell; 2013 Feb; 23(2):215-27. PubMed ID: 23410975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.
    Segal NH; Pavlidis P; Noble WS; Antonescu CR; Viale A; Wesley UV; Busam K; Gallardo H; DeSantis D; Brennan MF; Cordon-Cardo C; Wolchok JD; Houghton AN
    J Clin Oncol; 2003 May; 21(9):1775-81. PubMed ID: 12721254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
    Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
    Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.
    Yamada S; Imura Y; Nakai T; Nakai S; Yasuda N; Kaneko K; Outani H; Takenaka S; Hamada K; Myoui A; Araki N; Ueda T; Itoh K; Yoshikawa H; Naka N
    BMC Cancer; 2017 May; 17(1):334. PubMed ID: 28511645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New type of chimeric fusion product between the EWS and ATFI genes in clear cell sarcoma (malignant melanoma of soft parts).
    Pellín A; Monteagudo C; López-Ginés C; Carda C; Boix J; Llombart-Bosch A
    Genes Chromosomes Cancer; 1998 Dec; 23(4):358-60. PubMed ID: 9824209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Clear Cell Sarcoma of the Ileum: A Case Report With Next-Generation Sequencing Analysis.
    Zhu P; Zhang T; Bi K; Wu Y; Chen X; Zhang H; Huang D; Zhang L; Zeng Y; Yi X
    Int J Surg Pathol; 2021 Sep; 29(6):677-684. PubMed ID: 33412984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
    Matzke-Ogi A; Jannasch K; Shatirishvili M; Fuchs B; Chiblak S; Morton J; Tawk B; Lindner T; Sansom O; Alves F; Warth A; Schwager C; Mier W; Kleeff J; Ponta H; Abdollahi A; Orian-Rousseau V
    Gastroenterology; 2016 Feb; 150(2):513-25.e10. PubMed ID: 26597578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein.
    Bosilevac JM; Olsen RJ; Bridge JA; Hinrichs SH
    J Biol Chem; 1999 Dec; 274(49):34811-8. PubMed ID: 10574952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Iwata J; Furihata M; Ohtsuki Y
    J Pathol; 1999 Apr; 187(5):594-7. PubMed ID: 10398127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.
    Nakai T; Imura Y; Tamiya H; Yamada S; Nakai S; Yasuda N; Kaneko K; Outani H; Takenaka S; Hamada K; Myoui A; Araki N; Ueda T; Itoh K; Yoshikawa H; Naka N
    Cancer Med; 2017 Sep; 6(9):2121-2130. PubMed ID: 28745431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
    Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC
    BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell sarcoma expressing a novel chimerical transcript EWSR1 exon 7/ATF1 exon 6.
    Gineikiene E; Seinin D; Brasiuniene B; Brazaitis A; Griskevicius L; Jakubauskas A
    Virchows Arch; 2012 Sep; 461(3):339-43. PubMed ID: 22886438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma.
    Li BX; David LL; Davis LE; Xiao X
    J Biol Chem; 2022 Oct; 298(10):102434. PubMed ID: 36041632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
    Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
    Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway.
    Hosaka S; Horiuchi K; Yoda M; Nakayama R; Tohmonda T; Susa M; Nakamura M; Chiba K; Toyama Y; Morioka H
    J Orthop Res; 2012 Sep; 30(9):1493-8. PubMed ID: 22359392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
    Li KK; Lee KA
    Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.
    Canter RJ; Ames E; Mac S; Grossenbacher SK; Chen M; Li CS; Borys D; Smith RC; Tellez J; Sayers TJ; Monjazeb AM; Murphy WJ
    BMC Cancer; 2014 Oct; 14():756. PubMed ID: 25301268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.